Hangzhou Alltest Biotech Co., Ltd. Stock
Equities
688606
CNE1000053G6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
61.33 CNY | -3.23% | -10.55% | -10.60% |
Apr. 29 | China, HK stocks rise, led by property shares | RE |
Apr. 26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 3.39B 469M | Sales 2023 | 755M 104M | Capitalization | 5.36B 741M |
---|---|---|---|---|---|
Net income 2022 | 1.18B 164M | Net income 2023 | 181M 25.03M | EV / Sales 2022 | 0.51 x |
Net cash position 2022 | 3.79B 524M | Net cash position 2023 | 2.76B 382M | EV / Sales 2023 | 3.44 x |
P/E ratio 2022 |
4.75
x | P/E ratio 2023 |
30.1
x | Employees | 1,244 |
Yield 2022 |
9.58% | Yield 2023 |
2.19% | Free-Float | 33.28% |
1 day | -3.23% | ||
1 week | -10.55% | ||
Current month | -7.77% | ||
1 month | -10.90% | ||
3 months | +2.39% | ||
6 months | -16.91% | ||
Current year | -10.60% |
Managers | Title | Age | Since |
---|---|---|---|
Fei Gao
CEO | Chief Executive Officer | 50 | 14-06-30 |
Yan Ping Fu
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Wei Ke Lu
COO | Chief Operating Officer | 43 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fei Gao
CEO | Chief Executive Officer | 50 | 14-06-30 |
Hua Fang Zhao
BRD | Director/Board Member | 50 | 14-09-30 |
Wei Ke Lu
COO | Chief Operating Officer | 43 | 14-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 61.33 | -3.23% | 712 342 |
24-05-13 | 63.38 | -3.04% | 547,350 |
24-05-10 | 65.37 | -2.04% | 598,699 |
24-05-09 | 66.73 | -1.17% | 587,636 |
24-05-08 | 67.52 | +0.06% | 283,195 |
End-of-day quote Shanghai S.E., May 13, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-10.60% | 679M | |
-1.52% | 8.37B | |
+10.68% | 5.84B | |
+26.94% | 5.4B | |
-5.09% | 4.37B | |
-52.54% | 3.23B | |
+14.18% | 2.8B | |
+32.50% | 2.26B | |
-6.47% | 2.22B | |
-1.69% | 1.87B |
- Stock Market
- Equities
- 688606 Stock